These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 12883680)

  • 1. Mutation analysis of CTNNB1 (beta-catenin) and AXIN1, the components of Wnt pathway, in cervical carcinomas.
    Su TH; Chang JG; Yeh KT; Lin TH; Lee TP; Chen JC; Lin CC
    Oncol Rep; 2003; 10(5):1195-200. PubMed ID: 12883680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between protein expression and epigenetic and mutation changes of Wnt pathway-related genes in oral cancer.
    Yeh KT; Chang JG; Lin TH; Wang YF; Chang JY; Shih MC; Lin CC
    Int J Oncol; 2003 Oct; 23(4):1001-7. PubMed ID: 12963979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent genetic alterations and reduced expression of the Axin1 gene in oral squamous cell carcinoma: involvement in tumor progression and metastasis.
    Zhou CX; Gao Y
    Oncol Rep; 2007 Jan; 17(1):73-9. PubMed ID: 17143481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational activation of the RAS-RAF-MAPK and the Wnt pathway in small intestinal adenocarcinomas.
    Bläker H; Helmchen B; Bönisch A; Aulmann S; Penzel R; Otto HF; Rieker RJ
    Scand J Gastroenterol; 2004 Aug; 39(8):748-53. PubMed ID: 15513360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas.
    Taniguchi K; Roberts LR; Aderca IN; Dong X; Qian C; Murphy LM; Nagorney DM; Burgart LJ; Roche PC; Smith DI; Ross JA; Liu W
    Oncogene; 2002 Jul; 21(31):4863-71. PubMed ID: 12101426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Wnt-signaling pathway is not implicated in tumorigenesis of Merkel cell carcinoma.
    Liu S; Daa T; Kashima K; Kondoh Y; Yokoyama S
    J Cutan Pathol; 2007 Jan; 34(1):22-6. PubMed ID: 17214850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic alterations of Wnt signaling pathway-associated genes in hepatocellular carcinoma.
    Kim YD; Park CH; Kim HS; Choi SK; Rew JS; Kim DY; Koh YS; Jeung KW; Lee KH; Lee JS; Juhng SW; Lee JH
    J Gastroenterol Hepatol; 2008 Jan; 23(1):110-8. PubMed ID: 18171349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas.
    Dahmen RP; Koch A; Denkhaus D; Tonn JC; Sörensen N; Berthold F; Behrens J; Birchmeier W; Wiestler OD; Pietsch T
    Cancer Res; 2001 Oct; 61(19):7039-43. PubMed ID: 11585731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical analysis and mutational analyses of beta-catenin, Axin family and APC genes in hepatocellular carcinomas.
    Ishizaki Y; Ikeda S; Fujimori M; Shimizu Y; Kurihara T; Itamoto T; Kikuchi A; Okajima M; Asahara T
    Int J Oncol; 2004 May; 24(5):1077-83. PubMed ID: 15067328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational analysis of Wnt signaling molecules in ameloblastoma with aberrant nuclear expression of beta-catenin.
    Tanahashi J; Daa T; Yada N; Kashima K; Kondoh Y; Yokoyama S
    J Oral Pathol Med; 2008 Oct; 37(9):565-70. PubMed ID: 18284543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene mutation analysis and immunohistochemical study of beta-catenin in odontogenic tumors.
    Miyake T; Tanaka Y; Kato K; Tanaka M; Sato Y; Ijiri R; Inayama Y; Ito Y; Aoki S; Kawabe R; Tohnai I
    Pathol Int; 2006 Dec; 56(12):732-7. PubMed ID: 17096730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational, epigenetic and expressional analyses of caveolin-1 gene in cervical cancers.
    Chan TF; Su TH; Yeh KT; Chang JY; Lin TH; Chen JC; Yuang SS; Chang JG
    Int J Oncol; 2003 Sep; 23(3):599-604. PubMed ID: 12888893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological analysis of β-catenin and Axin-1 in solid pseudopapillary neoplasms of the pancreas.
    Huang SC; Ng KF; Yeh TS; Chang HC; Su CY; Chen TC
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S438-46. PubMed ID: 21769465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infrequent somatic mutations of the ICAT gene in various human cancers with frequent 1p-LOH and/or abnormal nuclear accumulation of beta-catenin.
    Imai M; Nakamura T; Akiyama T; Horii A
    Oncol Rep; 2004 Nov; 12(5):1099-103. PubMed ID: 15492799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No evidence for mutations or altered expression of the Suppressor of Fused gene (SUFU) in primitive neuroectodermal tumours.
    Koch A; Waha A; Hartmann W; Milde U; Goodyer CG; Sörensen N; Berthold F; Digon-Söntgerath B; Krätzschmar J; Wiestler OD; Pietsch T
    Neuropathol Appl Neurobiol; 2004 Oct; 30(5):532-9. PubMed ID: 15488029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large-scale N-terminal deletions but not point mutations stabilize beta-catenin in small bowel carcinomas, suggesting divergent molecular pathways of small and large intestinal carcinogenesis.
    Breuhahn K; Singh S; Schirmacher P; Bläker H
    J Pathol; 2008 Jul; 215(3):300-7. PubMed ID: 18491352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synchronous endometrioid carcinomas of the uterine corpus and ovary: alterations in the beta-catenin (CTNNB1) pathway are associated with independent primary tumors and favorable prognosis.
    Irving JA; Catasús L; Gallardo A; Bussaglia E; Romero M; Matias-Guiu X; Prat J
    Hum Pathol; 2005 Jun; 36(6):605-19. PubMed ID: 16021566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APC mutations are infrequent but present in human lung cancer.
    Ohgaki H; Kros JM; Okamoto Y; Gaspert A; Huang H; Kurrer MO
    Cancer Lett; 2004 Apr; 207(2):197-203. PubMed ID: 15072829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No difference in the occurrence of mismatch repair defects and APC and CTNNB1 genes mutation in a multi-racial colorectal carcinoma patient cohort.
    Tan LP; Ng BK; Balraj P; Lim PK; Peh SC
    Pathology; 2007 Apr; 39(2):228-34. PubMed ID: 17454753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Axin, the main component of the Wnt signaling pathway, is not mutated in kidney tumors in children.
    Miao J; Kusafuka T; Udatsu Y; Okada A
    Int J Mol Med; 2002 Apr; 9(4):377-9. PubMed ID: 11891531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.